iCAD is a leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of common cancers. iCAD offers a comprehensive range of high-performance, upgradeable CAD solutions for mammography and advanced image analysis and workflow solutions for Magnetic Resonance Imaging, for breast and prostate cancers and Computed Tomography for colorectal cancer. iCAD’s Xoft System, offers radiation treatment for early-stage breast cancer that can be administered in the form of intraoperative radiation therapy or accelerated partial breast irradiation. The Xoft System is also cleared for the treatment of non-melanoma skin cancer and endometrial cancer.
Company Growth (employees)
Type
Public
HQ
Nashua, US
Size (employees)
108 (est)
icad is headquartered in Nashua, US

icad Office Locations

icad has offices in Nashua and San Jose
Nashua, US (HQ)
98 Spit Brook Rd
San Jose, US
101 Nicholson Ln

icad Metrics

icad Financial Metrics

icad's revenue was reported to be $26.3 m in FY, 2016 which is a 37% decrease from the previous period.

Revenue (FY, 2016)

$26.3 m

Revenue growth (FY, 2015 - FY, 2016), %

(37%)

Gross profit (FY, 2016)

$18.5 m

Gross profit margin (FY, 2016), %

70%

Net income (FY, 2016)

($10.1 m)

EBIT (FY, 2016)

($10 m)

Market capitalization (23-May-2017)

$75.2 m

Closing share price (23-May-2017)

$4.8

Cash (31-Dec-2016)

$8.6 m
icad's current market capitalization is $75.2 m.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$5.6 m$43.9 m$41.6 m$26.3 m

Revenue growth, %

684%(5%)(37%)

Cost of goods sold

$10 m$12.7 m$12.2 m$7.8 m

Gross profit

($4.4 m)$31.2 m$29.4 m$18.5 m

Gross profit Margin, %

(78%)71%71%70%

Operating expense total

$24.9 m$30.4 m$59.4 m$28.5 m

EBIT

($1.8 m)$815 k($30.1 m)($10 m)

EBIT margin, %

(32%)2%(72%)(38%)

Interest expense

$3.3 m$2.6 m$650 k$63 k

Interest income

$19 k$37 k$21 k$10 k

Income tax expense

$126 k$153 k$16 k$76 k

Net Income

($7.6 m)($1 m)($32.4 m)($10.1 m)
FY, 2013FY, 2014FY, 2015FY, 2016

Cash

$11.9 m$32.2 m$15.3 m$8.6 m

Accounts Receivable

Inventories

$649 k$540 k$684 k$1.1 m

Current Assets

$22 m$44.6 m$27.8 m$19.9 m

Goodwill

$21.1 m$27.3 m$14.2 m$14.1 m

Total Assets

$58.9 m$93.8 m$48.6 m$38.7 m

Accounts Payable

$2 m$2.2 m$1.6 m$1.6 m

Current Liabilities

$22.5 m$22 m$14.3 m$12.9 m

Additional Paid-in Capital

$166.7 m$209.1 m$211.5 m$213.9 m

Retained Earnings

($144.1 m)($145.1 m)($177.5 m)($187.6 m)

Total Equity

$21.4 m$62.8 m$32.7 m$25 m

Financial Leverage

2.8 x1.5 x1.5 x1.5 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

($7.6 m)($1 m)($32.4 m)($10.1 m)

Depreciation and Amortization

$706 k$1.3 m$1.6 m$1.3 m

Accounts Receivable

($2.7 m)($840 k)$1.8 m$2.2 m

Inventories

$228 k($323 k)($2 m)$596 k

Accounts Payable

$60 k$150 k($557 k)($16 k)

Cash From Operating Activities

($1.4 m)$3.2 m($1.9 m)($5.5 m)

Purchases of PP&E

($539 k)($1.2 m)($932 k)($337 k)

Cash From Investing Activities

($707 k)($4.7 m)($2.7 m)($355 k)

Cash From Financing Activities

$72 k$21.9 m($12.4 m)($862 k)

Interest Paid

$2.2 m$1.6 m$558 k$70 k

Income Taxes Paid

$78 k$157 k$128 k$67 k
Y, 2016

Financial Leverage

1.5 x

icad Market Value History

icad Online Presence

icad Company Life

You may also be interested in